News

Celsion Corporation (Celsion) has received approval from the regulatory agencis in the Philippines and Malaysia for its pivotal phase III primary liver cancer clinical trial application. Reportedly, Celsion’s

QLT has restructured its agreement with Novartis to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive US rights to the

Bio-Bridge Science has received a business license from the Beijing Administration for Industry and Commerce of the People’s Republic of China (PRC) indicating approval of the formation of

Quotient Biodiagnostics (Quotient) has received FDA approval for its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products

Takeda Pharmaceutical (Takeda) has received approval from the Japanese Ministry of Health, Labour and Welfare for an additional indication of Basen Tablets 0.2 and Basen OD Tablets 0.2

ChemDiv of San Diego has said that its wholly owned subsidiary Chemical Diversity Research Institute (CDRI ) of Moscow, Russia, has been chosen by Viriom of Moscow, as

“For over 30 years, Thermo Fisher has thrived as a major employer in Frederick County,” Governor Kaine said. “By investing and expanding in the Commonwealth, Thermo Fisher will

Human Genome Sciences, (HGSI) has achieved a $75m milestone payment from Novartis, related to successful completion of the phase 3 development program and the decision to submit applications

Sanofi-Aventis has launched ClikSTAR in Canada. The Health Canada has approved the ClikSTAR reusable insulin pen for use with Lantus, giving patients with diabetes an additional option to